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Abstract
Introduction Less than 20 children with intramedullary
cavernoma (ImC) have been reported in the English
literature; however, cases with an unfavorable outcome
may be underreported. Whereas these are predominantly
boys, we report two girls who presented with hemato-
myelia (one cervical, one thoracic) and an acute, severe
neurological deficit.
Case material A 10-year-old girl complaining about lower
thoracic pain for several days suddenly developed lower
body dysesthesias and paraparesis. Magnetic resonance
(MR) demonstrated hematomyelia (T8–T11), intramedul-
lary edema (T6–L1), and an ImC at T9–T10. Within an
hour, she progressed to paraplegia and was therefore
operated immediately. She slowly recovered regaining
independent ambulation and continence. MR after 2 years
shows no recurrence. A 7-year-old girl suddenly devel-
oped cervicalgia and paresis of her left arm and leg. MR
demonstrated hematomyelia and an ImC at C4–C6. She
gradually recovered with minimal residual deficit at
3 months and was subsequently operated uneventfully.
Multiple cerebral cavernomas and a familial autosomal
cavernous malformation syndrome were diagnosed. The
following 1.5 years, she complained of intermittent
cervicalgia and left brachial dysesthesias, with MR
suggesting active residual cavernoma. Interestingly, her
complaints gradually disappeared, and she is currently
asymptomatic. MR after 3.5 years shows minimal cord
swelling no longer suggesting active residual cavernoma.
Conclusion With adequate surgical treatment either in the
acute phase in case of dramatic deterioration or after clinical
recuperation, prognosis of symptomatic ImC may be surpris-
ingly good. However, subtotally resected lesions and/or
syndromal cases may recur, requiring further treatment.
Definitive answers await more cases with longer follow-up.
Keywords Cavernoma.Genetics.Hematomyelia.
Intramedullarycavernousangioma.Pediatricneurosurgery
Introduction
Intramedullary cavernomas (ImC) are rare lesions especially
in children, in whom they represent 1% of all intramedullary
lesions [23]. As such, less than 20 symptomatic cases have
been reported in the English literature [1, 2, 6, 9, 10, 16,
18–20, 23–25] and predominantly in boys (Table 1). These
invariably presented with an acute, severe neurological
deficit followed by rapid deterioration due to hematomyelia
[23]. Confronted with such a dramatically affected patient,
the attending neurosurgeon, due to the rarity of the
condition, finds no guidelines in the literature and has to
decide if and when to operate on a case-by-case basis,
based on the child’s clinical presentation, magnetic reso-
nance (MR) findings, and his or her personal preference.
We report two girls presenting with hematomyelia (one
cervical, one thoracic) and an acute, severe neurological
deficit. We present their clinical and radiological details as
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the girls turned out to have a familial autosomal cavernous
malformation syndrome, we review the pertinent literature
as well.
Case material
Case 1
History and examination
A 10-year-old girl complaining about dorsalgia for several
days suddenly developed lower body dysesthesias and a
paraparesis. An L1 sensory-motor level, lower limb hyper-
reflexia including Babinski’s signs, and decreased rectal
sphincter tone were noted. Emergency MR demonstrated
hematomyelia (T8–T11), intramedullary edema (T6–L1),
a n da nI m Ca tT 9 –T10 (Fig. 1a) .W i t h i n2ha f t e r
admission, paraparesis progressed to paraplegia, and there-
fore, the girl was operated immediately.
Operation
We had no time to localize the lesion preoperatively.
Consequently, we removed three thoracic laminae and two
more after durotomy revealing insufficient exposure of the
lesion, which appeared as a dark blue clot shining through
the pia mater. After midline myelotomy, the hematoma
presented itself, and the cavernoma was gently mobilized
and resected.
Postoperative course
The girl slowly recovered, regaining minimal voluntary
movement after 10 days, continence after 9 months, and
independent ambulation after 12 months. Early postopera-
tive MR confirmed complete resection of an apparently
solitary cavernoma (Fig. 1b), whereas 2 years postoperative
MR shows a thin spinal cord without evidence of local
recurrence (Fig. 1c) and a kyphoscoliosis which we are
closely following (Fig. 1d).
Case 2
History and examination
One day after a fall during skating, a 7-year-old girl
suddenly developed cervicalgia and severe paresis of her
left arm and leg (grades 1–2 out of 5 according to the
American Spinal Injury Association). MR demonstrated
hematomyelia at C4–C6 and an ImC at C5 (Fig. 2a). Within
Table 1 Clinical characteristics of children with intramedullary cavernoma in the literature
Authors Gender Age (years) ImC anatomical level ImC multiple levels
Odom et al. [20] F 13 C3–C4 No
McCormick et al. [16] M 15 T8–T9 No
Anson and Spetzler [1] F 14 C2 Cerebral cavernomas and familial history
M1 7 C 3 –C7 No
Furuya et al. [9] F 14 T10–T11 Unknown
Tu et al. [25]M 7 C 3 –C4 Unknown
M1 8 C 7 –T1 Unknown
Scott et al. [24] M 13 Cervical spinal cord Unknown
Deutsch et al. [6] M 13 T3 4 intracranial cavernomas
M 8 C2 6 intracranial cavernomas
Nagib and O’Fallon [18] M 10 T4 Unknown
F 16 T4 Unknown
Bakir et al. [2] M 14 C6–C7 Unknown
Jallo et al. [10] M 13 T4 7
M 8 C1 6
M1 8 C 7 –T1 No
M1 8 T 1 –T2 No
Santoro et al. [23] M 11 C1 4 cerebral and 1 pontine cavernoma
Noudel et al. [19] F 12 T11 No
Present study F 7 C5 No
F1 0 T 9 –T10 No
C cervical, F female, ImC intramedullary cavernoma, M male, T thoracic
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3 months, her residual deficit was minimal.
Operation
At that time, she was operated using a C3–C7 laminoplastic
technique and motor evoked potential monitoring. The cord
at C4–C5 was clearly swollen, and the exact position of the
cavernoma was determined using ultrasonography
(Fig. 3b). Subtle subpial yellow-blue discoloration was
apparent after sectioning the left C4–C5 denticulate
ligament and gently rotating the spinal cord to the right
(Fig. 3a). After lateral myelotomy, the hematoma presented
itself; however, mobilizing and resecting the cavernoma
was difficult due to a rather limited lateromedial view
inside the spinal cord.
Postoperative course
The girl did well after the operation showing no new
neurological deficits. Multiple small cerebral cavernomas
and a familial autosomal cavernous malformation syn-
drome were diagnosed with mutation of the MGC4607/
malcavernin/CCM2-gen (Fig. 2b). The following 1.5 years,
she complained of intermittent cervicalgia and left brachial
dysesthesias, with MR suggesting active residual caver-
noma (Fig. 2c). Interestingly, her complaints gradually
disappeared, and she is currently asymptomatic. MR after
3.5 years shows minimal cord swelling no longer suggest-
ing active residual cavernoma (Fig. 2d).
Discussion
Incidence, clinical presentation, and bleeding risk
ImC are rare lesions in adults but even more in children,
representing 5% and 1%, respectively, of all intramedullary
lesions at tertiary referral centers [5, 23]. As such, less than
20 symptomatic children have been reported in the English
literature [1, 2, 6, 9, 10, 16, 18–20, 23–25] (Table 1),
invariably presenting with an acute, severe neurological
deficit followed by rapid deterioration due to hematomyelia
[23]. Adults, on the other hand, present with slowly
progressive deficits or an acute deficit followed by a slow,
stepwise deterioration with episodes of some clinical
b1 b2 b3
c1 c2 c3
Fig. 1 a1–a3 Preoperative sagittal T1, T2, and T2 FFE (fast field
echo) MR images revealing a markedly swollen cord, including
intramedullary edema (T6–L1), hematomyelia (T8–T11), and an ImC
at T9–T10; b1–b3 3 months postoperative sagittal T1, T2, and axial
T2 MR images confirming complete resection; c1–c3 2y e a r s
postoperative sagittal T1, T2, and axial T2 MR images demonstrating
a thin spinal cord without evidence of local recurrence; d1, d2 2 years
postoperative anteroposterior and lateral spinal X-rays to monitor
kyphoscoliosis
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lowed by gliosis or iterative thrombosis within the
cavernoma [8, 15, 19]. Our first patient complained about
dorsalgia for several days and then suddenly developed
lower body dysesthesias and a paraparesis, which within
2 h after admission progressed to paraplegia. Our second
patient suddenly developed cervicalgia and severe paresis
of her left arm and leg 1 day after a fall. The acute
presentation in both cases is in line with the literature;
however, the second patient remained in stable clinical
condition over the following days and therefore did not
require emergency surgery.
The clinical presentation of ImC in general is quite
variable, often including both sensory and motor symp-
toms, resulting in pain and paresis. As such, Zevgaridis
et al. [29] distinguished three major patterns in the clinical
course of 117 symptomatic ImC in patients between 12
and 88 years old. Group A (30%) suffered multiple
episodes of discrete neurological deterioration and varying
degrees of recovery in between. Group B (41%) suffered
slowly progressive neurological deterioration. Group C
(26%) suffered sudden onset of symptoms and rapid
decline over hours or days (C1, 16%), which is common
in children [10, 18], or a little slower over several weeks
(C2, 10%). Clearly both cases presented in this report
belong to group C1.
There is no literature specifically addressing the bleeding
risk of ImC in pediatric patients. Most clinical series deal
mainly or exclusively with adult patients and demonstrate a
higher bleeding risk (regardless of age) for ImC as
compared to their cerebral counterparts: the annual
bleeding risk for cerebral cavernomas is believed to be
about 0.7–1.3% [3, 13, 21], for brainstem cavernomas
about 2.7% [19], and for ImC about 1.6–4.5% [18, 19, 22].
Moreover, the potential that hemorrhage may cause
significant morbidity is higher for ImC than for their
a1
a2
a3
b1
b2
c1
c2
d1
d2
Fig. 2 a1–a3 Preoperative sagittal T1, T2, and axial T2 MR images
revealing a markedly swollen cord, including hematomyelia at C4–C6
and a left anterolateral ImC at C5; b1, b2 3 months postoperative
sagittal T2 and axial T2 FFE (fast field echo) MR images, note
multiple small cerebral cavernomas; c1, c2 2.5 years postoperative
sagittal and axial T2 MR images, the cord still appears swollen; d1, d2
3.5 years postoperative sagittal and axial T2 MR images, the cord now
appears less swollen and the child is asymptomatic
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tous space in which ImC are located.
Gender distribution and age at presentation
Deutsch et al. [5] postulated that adult ImC are equally
distributed among both sexes; however, a female predispo-
sition in those presenting with hemorrhage (female/male
ratio 2:1) [29] may be attributable to a hormonal effect
increasing the risk of hemorrhage. More recently, Santoro et
al. [23] performed an extensive literature review and
calculated a female/male ratio of 1.1:1. In contrast, a male
predisposition is reported in children (female/male ratio
1:2), and the mean age they present with hematomyelia is
9.1 years (range 7 months–17 years) according to Scott et
al. [24] or 13.2 years (range 8–17 years) according to
Noudel et al. [19]. In this regard, some authors believe that
hormonal factors may influence the clinical onset of
cavernomas in puberty [19]. Our report adds two girls to
the literature and challenges the reported male predisposi-
tion in children (Table 1).
Imaging characteristics, anatomical distribution,
and genetic predisposition
MR is the golden standard to diagnose cavernomas in
any location, as myelography and computed tomography
are much less sensitive [1] and cavernomas are angio-
graphically occult [12]. ImC typically have a mixed signal
intensity on MR scans, including a hyperintense core
lesion and a rim of low signal intensity caused by
hemosiderin deposition around the cavernoma on T2-
weighted images [1]. Their size varies from 0.8–5.4 cm
(mean 1.4–1.7 cm) [3, 5, 10, 15], and typically, they are
small, round, or ovoid well-defined lesions [5, 10]s i t u a t e d
dorsolaterally in the spinal cord [25]w h e r et h e ym a y
reach the surface. The ImC in our patients were of
intermediate size and situated dorsomedially (case 1) and
left (dorso)laterally (case 2). The extent of hematomyelia
(T8–T11) and intramedullary edema (T6–L1) in the
former patient, however, made an exact delineation of
the cavernoma difficult.
According to the literature, ImC in adults are more
common in the thoracic cord, whereas ImC in children
are equally distributed in the cervical and thoracic cord
[18, 19]( T a b l e1). As such, our first patient had a
cavernoma at T9–T10 and our second patient at C5.
Importantly, ImC may occur in association with cerebral
or systemic lesions [1, 10]. Multiple lesions are typically
seen in the so-called inherited cerebral cavernous malfor-
mation disorder [17], which was diagnosed in our second
patient. To date, three loci have been identified for this
disorder: CCM1 on chromosome arm 7q, CCM2 on 7p
(our second patient), and CCM3 on 3q, which may be
responsible for approximately 40–50%, 10–20%, and 40%
of inherited cases, respectively [4, 7]. In fact, as many as
12–40% [5, 10] of patients and especially children and
young adults with ImC have other cavernomas in their
central nervous system (Table 1). Complete neuraxis
imaging in all patients and particularly in the younger
age group is therefore mandatory [10, 27].
Few cases have been reported with multifocal (intra-
medullary and cerebral) cavernomas yet without a positive
family history, and several theories have been proposed to
explain their occurrence: a neoplast-like process with
hormonal influence during pregnancy, the possible seeding
of a lesion along a biopsy track, the intralesional presence
of endothelial cell expressing proliferating cell nuclear
antigen, the occurrence of cavernomas in areas previously
a
b
Fig. 3 a Macroscopic intraoperative image at C4–C5 (left dorsolateral
view, one denticulate ligament sectioned) showing subtle subpial
yellow-blue discoloration at the lateral surface of the spinal cord. b
Ultrasonic intraoperative image at C3–C6 (sagittal view) specifying
the exact location of the cavernoma in the swollen cord segment
Childs Nerv Syst (2010) 26:391–398 395irradiated, and an incomplete penetrance or even a
misdiagnosis of the disease [17, 23, 28].
Surgical strategy and outcome
Some authors recommend resection for every patient with
symptomatic ImC and even for those who have minimal
symptoms [10, 24]. They argue that once symptoms and
signs caused by hemorrhage have appeared, the patient will
likely experience future neurological decline, whereas after
microsurgical resection by experienced hands, a stable or
improved functional status is achieved in 92–94% of
patients [10, 29] independent of age, gender, and lesion
location [29]. On the other hand, Kharkar et al. [11]
recently evaluated the natural history of conservatively
managed symptomatic ImC and did not observe a signif-
icant, permanent neurological decline in a cohort of ten
patients during a mean follow-up period of 80 months. Of
note, all but one were adult patients who may have a
different clinical course as previously outlined, and the
study design was retrospective nonrandomized (conserva-
tively managed patients presenting mainly with paresthe-
sias, surgically managed patients presenting mainly with
pain and paresis). The authors carefully conclude that they
may have identified a distinct subgroup of patients with
symptomatic ImC that may have a much lower risk of
rehemorrhage.
Most neurosurgeons would agree that dissection must be
confined to the thin layer of hemosiderin laden gliosis
surrounding the ImC to limit damage to the normal adjacent
spinal cord tissue. According to some authors [19], this
would even obviate the use of neurophysiological monitor-
ing which they consider time-consuming and of debated
reliability. Others including us prefer neurophysiological
monitoring for every elective intramedullary resective
procedure [6, 10, 14]. Furthermore, intraoperative ultra-
sound typically shows a hypointense signal at the site of
recent hemorrhage [10], helps to localize the lesion if not
readily visible on the cord surface [25], and helps to
determine the optimal entry point to approach the lesion.
There is considerably more debate regarding the optimal
timing for resection, which is simply not known, and
factors such as severity of the patients clinical condition,
presence (or absence) of clinical progression, anatomical
level of the lesion, and attending surgeons experience
would be taken into account. Some authors propose 4 to
6 weeks after hemorrhage as an optimal time to operate, as
during such time interval, a gliotic plane would have
formed around the cavernoma, enabling the surgeon to
safely separate cavernoma from surrounding cord tissue
[10, 12, 29]. This is exactly what we did in case 2, who
remained in stable clinical condition initially and then
gradually recovered until she was operated 3 months after
hemorrhage. In case 1 who rapidly progressed to paraplegia,
we did not hesitate to operate immediately, and fortunately,
the girl demonstrated remarkable recovery regaining conti-
nence and independent ambulation over the following
months. In fact, in such situation, there may be imminent
spinalcord infarctiondue toa steep pressure rise inthe spinal
cord, which is lined by nonelastic pia mater. Therefore, rapid
pressure relief may be the only way to prevent irreversible
spinal cord infarction.
It is essential to achieve radical removal during the first
operation because any ImC residue may lead to further
hemorrhage [23], and a second operation may present
greater surgical difficulties. Rebleeding risk may be as high
as 17.6% according to Vishteh et al. [27] or even 66%
according to Sandalcioglu et al. [22]a n dm a yc a u s e
recurrent myelopathy (9%) [26]. Whereas our first patient
clearly has no residual cavernoma on postoperative MR
scans, our second patient seemed to have an actively
leaking residual cavernoma on initial follow-up MR scans
and complained of intermittent cervicalgia and left brachial
dysesthesias for approximately 1.5 years postoperatively.
Interestingly, her complaints gradually disappeared and she
is currently asymptomatic. MR after 3.5 years shows
minimal cord swelling no longer suggesting active residual
cavernoma. Little if anything is found in the literature
concerning the difficult dilemma between follow-up and
reoperation in case of residual cavernoma, especially in the
setting of multiple cavernomas in children who have a long
life expectancy and are otherwise doing fine. It is generally
believed subtotally resected lesions and/or syndromal cases
tend to recur [1, 10, 12, 18, 24, 26]. In this regard, Scott et
al. [24] have suggested that central nervous system
cavernomas may frequently bleed silently, producing low-
pressure small-volume hemorrhages which are radiologi-
cally invisible. Such hemorrhages may not be of a critical
volume or may not be in a critical location and therefore
may not be life threatening; however, they may expand
with time and irritate the spinal cord, which may become
gliotic and edematous [10, 24]. On the other hand, one
should keep in mind that especially early postoperative MR
images may be misleading and therefore misinterpreted, as
low-intensity signals of postoperative scar tissue may be
misdiagnosed for residual cavernoma and that MR images
may become more reliable at least 6 months postoperatively
[19]. Clearly, definitive answers await more cases with
longer follow-up, and until then, surgical decisions have to
be made on a case-by-case basis.
Finally, therapeutic indications remain controversial for
asymptomatic ImC in sporadic as well as nonsporadic cases
[19]. Some recommend surgical resection for readily
accessible ImC [5, 6, 22], whereas others recommend an
expectant policy and regular clinicoradiological follow-up
for deeper lesions [1–3, 10, 12].
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Vishteh et al. [26] reported delayed complications in four of
17 patients (23.5%) with surgically treated ImC. These
complications were mainly symptomatic rehemorrhage as a
result of incomplete resection, or less frequently symptom-
atic spinal cord tethering. Clinical symptoms of spinal cord
tethering include severe headaches, neck pain, arm or leg
pain irresponsive to medical therapy, and/or progressive
neurological deficit, which are all related to the level of
spinal cord tethering. Surgical detethering is indicated in
patients who develop new or progressive symptoms in the
late postoperative period and are radiographically suspect
for tethering. In children, spinal deformity is another
potential complication after multilevel laminectomy [18].
As children may develop delayed spinal deformity and/or
spinal cord tethering during longitudinal growth, regular
radiological follow-up is indicated until they have reached
adult stature (Fig. 1d). Whether such spinal deformity may
be prevented by replacement laminoplasty techniques
remains a matter of debate [18, 19].
Conclusion
Less than 20 children with ImC have been reported in the
English literature; however, cases with an unfavorable
outcome may be underreported. We report two girls
presenting with an acute, severe neurological deficit due
to hematomyelia, thereby challenging the male predomi-
nance in this age group. MR of the entire neuraxis is
mandatory, as these children are more likely to harbor a
familial autosomal cavernous malformation syndrome.
With adequate surgical treatment either in the acute phase
or after clinical recuperation, prognosis may be surprisingly
good. Incompletely resected lesions and/or syndromal cases
may recur, requiring further treatment. Definitive answers
await more cases with longer follow-up especially after
subtotal resection; however, as long as patients remain in
stable condition, careful clinical and radiological follow-up
may be an alternative to reoperation.
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